Journal List > Tuberc Respir Dis > v.69(4) > 1001539

Kim, Lee, Kim, Park, Jeon, Kim, Lee, and Park: Risk Factors Associated with Frequent Hospital Readmissions for Exacerbation of COPD

Abstract

Background:

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of disability and mortality worldwide. The aim of this study was to evaluate the risk factors associated with recurrent hospital admissions for exacerbation of COPD in Korea.

Methods:

A retrospective study of 77 consecutive patients hospitalized for exacerbation of COPD at Pusan National University Hospital during the time period January 2005 to May 2008 was performed. The information was collected from the hospitalization period: clinical information, spirometric measures, and laboratory variables. In addition, socioeconomic characteristics, co-morbidity, anxiety, and depression were reviewed. Frequent readmission was defined as 2 or more hospitalizations in the year following discharge.

Results:

During the 1-year period after discharge, 42 patients (54.6%) reported one hospital admission and 35 patients (45.4%) reported 2 or more hospital readmissions. Among the 35 frequent readmission patients, 4 had more than 10 readmissions. Univariate analysis showed that a body mass index (BMI) <18.5 kg/m2, duration >36 months, forced expiratory volume in 1 second (FEV1) <50% predicted, arterial CO2 partial pressure (PaCO2) >40 mm Hg, and arterial oxygen saturation (SaO2) <95% at discharge were associated significantly with frequent readmissions. The multivariate analysis revealed that BMI <18.5 kg/m2, PaCO2 >40 mm Hg at discharge were independently associated with frequent readmissions for exacerbation of COPD.

Conclusion:

Frequent readmissions for exacerbation of COPD were associated with low BMI and hypercapnia at discharge.

REFERENCES

1.Siafakas NM., Vermeire P., Pride NB., Paoletti P., Gibson J., Howard P, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995. 8:1398–420.
2.Rabe KF., Hurd S., Anzueto A., Barnes PJ., Buist SA., Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007. 176:532–55.
3.O'byrne PM., Postma DS. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med. 1999. 159:S41–63.
4.The National Lung Health Education Program (NLHEP). Strategies in preserving lung health and preventing COPD and associated diseases. Chest. 1998. 113(Suppl 2):123S-63S.
5.Ashutosh K., Haldipur C., Boucher ML. Clinical and personality profiles and survival in patients with COPD. Chest. 1997. 111:95–8.
crossref
6.Douglas SL., Daly BJ., Gordon N., Brennan PF. Survival and quality of life: short-term versus long-term ventilator patients. Crit Care Med. 2002. 30:2655–62.
crossref
7.National Heart, Lung and Blood Institute, National Institutes of Health. Morbidity and mortality: 2007 chart book on cardiovascular, lung and blood diseases [Internet]. Bethesda, MD: National Institutes of Health;2007. [cited 2010 Oct 14]. Available from:. http://www.nhlbi.nih.gov/resources/docs/07a-chtbk.pdf.
8.Connors AF Jr., Dawson NV., Thomas C., Harrell FE Jr., Desbiens N., Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996. 154:959–67.
crossref
9.Murata GH., Gorby MS., Kapsner CO., Chick TW., Halperin AK. A multivariate model for the prediction of relapse after outpatient treatment of decompensated chronic obstructive pulmonary disease. Arch Intern Med. 1992. 152:73–7.
crossref
10.Roberts CM., Lowe D., Bucknall CE., Ryland I., Kelly Y., Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2002. 57:137–41.
crossref
11.Garcia-Aymerich J., Farrero E., Félez MA., Izquierdo J., Marrades RM., Antó JM, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003. 58:100–5.
crossref
12.Lau AC., Yam LY., Poon E. Hospital readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Med. 2001. 95:876–84.
crossref
13.Vega Reyes JA., Montero Pérez-Barquero M., Sánchez Guijo P. Assessing COPD-associated morbidity: factors of prognosis. Med Clin (Barc). 2004. 122:293–7.
14.Cydulka RK., McFadden ER Jr., Emerman CL., Sivinski LD., Pisanelli W., Rimm AA. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997. 156:1807–12.
crossref
15.Stehr DE., Klein BJ., Murata GH. Emergency department return visits in chronic obstructive pulmonary disease: the importance of psychosocial factors. Ann Emerg Med. 1991. 20:1113–6.
crossref
16.Osman IM., Godden DJ., Friend JA., Legge JS., Douglas JG. Quality of life and hospital readmission in patients with chronic obstructive pulmonary disease. Thorax. 1997. 52:67–71.
crossref
17.Tsoumakidou M., Tzanakis N., Voulgaraki O., Mitrouska I., Chrysofakis G., Samiou M, et al. Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med. 2004. 98:178–83.
crossref
18.Kessler R., Faller M., Fourgaut G., Mennecier B., Weitzen-blum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999. 159:158–64.
crossref
19.Pouw EM., Ten Velde GP., Croonen BH., Kester AD., Schols AM., Wouters EF. Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr. 2000. 19:95–9.
crossref
20.Sahebjami H., Sathianpitayakul E. Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000. 161:886–90.
crossref
21.Costello R., Deegan P., Fitzpatrick M., McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med. 1997. 102:239–44.
crossref
22.Haidl P., Clement C., Wiese C., Dellweg D., Köhler D. Long-term oxygen therapy stops the natural decline of endurance in COPD patients with reversible hypercapnia. Respiration. 2004. 71:342–7.
crossref
23.Garcia-Aymerich J., Monsó E., Marrades RM., Escarrabill J., Félez MA., Sunyer J, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001. 164:1002–7.
24.Miravitlles M., Guerrero T., Mayordomo C., Sánchez-Agu-do L., Nicolau F., Segú J; JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration. 2000. 67:495–501.
25.Lorenzi CM., Cilione C., Rizzardi R., Furino V., Bellantone T., Lugli D, et al. Occupational therapy and pulmonary rehabilitation of disabled COPD patients. Respiration. 2004. 71:246–51.
crossref
26.Bourbeau J., Julien M., Maltais F., Rouleau M., Beaupré A., Bégin R, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003. 163:585–91.
crossref
27.Pascual-Pape T., Badia JR., Marrades RM., Hernández C., Ballester E., Fornas C, et al. Results of a preventive program and assisted hospital discharge for COPD exacerbation. A feasibility study. Med Clin (Barc). 2003. 120:408–11.
28.Puente-Maestu L., SantaCruz A., Vargas T., Martínez-Abad Y., Whipp BJ. Effects of training on the tolerance to high-intensity exercise in patients with severe COPD. Respiration. 2003. 70:367–70.
crossref

Table 1.
Baseline characteristics of COPD patients with frequent and non-frequent readmissions
Variables All (n=77) Frequent (n=35) Non-frequent (n=42) p-value
Sex
  Male 64 (83.1) 30 (85.7) 34 (81) 0.546
  Female 13 (16.9) 5 (14.3) 8 (29.0)  
Age, years±SD 69.2±9.4 68.2±9.9 70.1±9.1  
  ≥65 55 (71.4) 24 (68.6) 31 (73.8) 0.466
  <65 22 (28.6) 11 (31.4) 11 (26.2)  
Smoking (Pack-year) 44.8±25.6 42.1±26.5 47.2±24.9  
  Non-smoker 14 (18.2) 7 (20.0) 7 (16.6) 0.619
  Ex&current smoker 63 (81.2) 28 (80.0) 35 (83.4)  
BMI, kg/m2
  ≥18.5 25 (32.5) 6 (17.2) 22 (52.4) <0.001
  <18.5 52 (67.5) 29 (82.8) 20 (47.6)  
Anxiety or depression        
  Yes 9 (11.9) 7 (20.0) 2 (4.8) 0.072
  No 68 (88.3) 28 (80.0) 40 (95.2)  
Previous steroid therapy
  Yes 25 (32.5) 18 (54.3) 7 (16.7) 0.053
  No 46 (59.7) 16 (45.7) 30 (71.4)  
  Unknown 6 (7.8) 1 (0.0) 5 (11.9)  

Data are presented as number (%).

COPD: chronic obstructive pulmonary disease; BMI: body mass index.

Table 2.
Respiratory function of COPD patients with frequent and non-frequent readmissions
Variables All (n=77) Frequent (n=35) Non-frequent (n=42) p-value
Duration of COPD, months±SD 62.38±92.07 83.97±112.44 43.56±65.60  
  ≥36 40 (51.9) 23 (65.7) 17 (40.5) 0.010
  <36 37 (48.1) 12 (34.3) 25 (59.5)  
COPD severity
  Mild & moderate 34 (44.1) 11 (31.4) 23 (54.8) 0.051
  Severe & very severe 43 (55.9) 24 (68.6) 19 (45.2)  
FEV1% predicted
  ≥50 23 (29.9) 6 (17.1) 17 (40.5) <0.001
  <50 54 (80.1) 29 (82.9) 25 (59.5)  
SaO2 at discharge
  ≥95% 29 (37.7) 13 (37.1) 16 (38.1) 0.022
  <95% 48 (62.3) 22 (62.9) 26 (61.9)  
PaCO2 at discharge
  ≥40 mm Hg 33 (42.9) 24 (68.6) 9 (21.4) <0.001
  <40 mm Hg 44 (57.1) 11 (31.4) 33 (78.6)  

Data are presented as number (%).

COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in 1 second; SaO2: arterial oxygen saturation; PaCO2 arterial CO2 partial pressure.

Table 3.
Associated factors of frequent readmission in COPD (univariate analysis)
Variables OR 95% CI p-value
Duration of COPD (≥36 months) 3.409 1.318∼8.817 0.010
BMI (kg/m2) <18.5 4.912 1.648∼14.638 <0.001
FEV1 <50% predicted 4.765 1.745∼13.007 <0.001
SaO2 at discharge <95% 2.933 1.152∼7.471 0.022
PaCO2 at discharge >40 mm Hg 7.758 2.776∼21.679 <0.001

COPD: chronic obstructive pulmonary disease; OR: odds ratio; CI: confidence interval; BMI: body mass index; FEV1: forced expiratory volume in 1 second; SaO2: arterial O2 saturation; PaCO2: arterial CO2 partial pressure.

Table 4.
Multiple logistic regression analysis of the association with frequent readmission in COPD
Significant independent predictors OR 95% CI p-value
BMI (kg/m2) <18.5 5.306 1.254~22.454 0.023
PaCO2 at discharge 4.213 1.193~14.880 0.025
>40 mm Hg      

COPD: chronic obstructive pulmonary disease; OR: odds ratio; CI: confidence interval; BMI: body mass index; PaCO2: arterial CO2 partial pressure.

TOOLS
Similar articles